Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C20H6Br4O5.2Na |
| Molecular Weight | 691.854 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].[Na+].[O-]C(=O)C1=C(C=CC=C1)C2=C3C=C(Br)C(=O)C(Br)=C3OC4=C2C=C(Br)C([O-])=C4Br
InChI
InChIKey=SEACYXSIPDVVMV-UHFFFAOYSA-L
InChI=1S/C20H8Br4O5.2Na/c21-11-5-9-13(7-3-1-2-4-8(7)20(27)28)10-6-12(22)17(26)15(24)19(10)29-18(9)14(23)16(11)25;;/h1-6,25H,(H,27,28);;/q;2*+1/p-2
| Molecular Formula | C20H6Br4O5 |
| Molecular Weight | 645.875 |
| Charge | -2 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | Na |
| Molecular Weight | 22.98976928 |
| Charge | 1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Acid Red 87, also known as Eosin Y, used as an acidic red stain for cell cytoplasm and as a background stain, thereby giving contrast to the nuclear stains. In histopathology, it is applied as a counterstain after hematoxylin and before methylene blue. Acid Red 87 is also a dye photosensitizer that catalyzes electron-transfer reaction for efficient regeneration of NADH through a photosensitizer-electron relay dyad. Recently was shown that the combination of eosin Y with light-emitting diode produced bacterial inactivation, being a potential candidate for photodynamic inactivation.
Approval Year
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/29575393
Bacteria (107 CFU per ml) were incubated with eosin Y (ACID RED 87) at concentrations ranging from 0·1 to 10 μmol l-1 , irradiated by green LED (λmax 490-570 nm) for 5, 10 and 15 min and the cellular viability was determined. Pseudomonas aeruginosa was completely inactivated when treated with 10 μmol l-1 eosin Y for 10 min.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:29:18 GMT 2025
by
admin
on
Mon Mar 31 18:29:18 GMT 2025
|
| Record UNII |
TDQ283MPCW
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Preferred Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-ATC |
D08AX02
Created by
admin on Mon Mar 31 18:29:18 GMT 2025 , Edited by admin on Mon Mar 31 18:29:18 GMT 2025
|
||
|
WHO-VATC |
QD08AX02
Created by
admin on Mon Mar 31 18:29:18 GMT 2025 , Edited by admin on Mon Mar 31 18:29:18 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000078924
Created by
admin on Mon Mar 31 18:29:18 GMT 2025 , Edited by admin on Mon Mar 31 18:29:18 GMT 2025
|
PRIMARY | |||
|
2087
Created by
admin on Mon Mar 31 18:29:18 GMT 2025 , Edited by admin on Mon Mar 31 18:29:18 GMT 2025
|
PRIMARY | |||
|
CHEMBL408917
Created by
admin on Mon Mar 31 18:29:18 GMT 2025 , Edited by admin on Mon Mar 31 18:29:18 GMT 2025
|
PRIMARY | |||
|
4466
Created by
admin on Mon Mar 31 18:29:18 GMT 2025 , Edited by admin on Mon Mar 31 18:29:18 GMT 2025
|
PRIMARY | |||
|
SUB13680MIG
Created by
admin on Mon Mar 31 18:29:18 GMT 2025 , Edited by admin on Mon Mar 31 18:29:18 GMT 2025
|
PRIMARY | |||
|
125399-78-2
Created by
admin on Mon Mar 31 18:29:18 GMT 2025 , Edited by admin on Mon Mar 31 18:29:18 GMT 2025
|
ALTERNATIVE | |||
|
241-409-6
Created by
admin on Mon Mar 31 18:29:18 GMT 2025 , Edited by admin on Mon Mar 31 18:29:18 GMT 2025
|
PRIMARY | |||
|
m4928
Created by
admin on Mon Mar 31 18:29:18 GMT 2025 , Edited by admin on Mon Mar 31 18:29:18 GMT 2025
|
PRIMARY | Merck Index | ||
|
548-26-5
Created by
admin on Mon Mar 31 18:29:18 GMT 2025 , Edited by admin on Mon Mar 31 18:29:18 GMT 2025
|
ALTERNATIVE | |||
|
DB13706
Created by
admin on Mon Mar 31 18:29:18 GMT 2025 , Edited by admin on Mon Mar 31 18:29:18 GMT 2025
|
PRIMARY | |||
|
11048
Created by
admin on Mon Mar 31 18:29:18 GMT 2025 , Edited by admin on Mon Mar 31 18:29:18 GMT 2025
|
PRIMARY | |||
|
DTXSID0025234
Created by
admin on Mon Mar 31 18:29:18 GMT 2025 , Edited by admin on Mon Mar 31 18:29:18 GMT 2025
|
PRIMARY | |||
|
TDQ283MPCW
Created by
admin on Mon Mar 31 18:29:18 GMT 2025 , Edited by admin on Mon Mar 31 18:29:18 GMT 2025
|
PRIMARY | |||
|
EOSIN Y
Created by
admin on Mon Mar 31 18:29:18 GMT 2025 , Edited by admin on Mon Mar 31 18:29:18 GMT 2025
|
PRIMARY | |||
|
52053
Created by
admin on Mon Mar 31 18:29:18 GMT 2025 , Edited by admin on Mon Mar 31 18:29:18 GMT 2025
|
PRIMARY | |||
|
TDQ283MPCW
Created by
admin on Mon Mar 31 18:29:18 GMT 2025 , Edited by admin on Mon Mar 31 18:29:18 GMT 2025
|
PRIMARY | |||
|
17372-87-1
Created by
admin on Mon Mar 31 18:29:18 GMT 2025 , Edited by admin on Mon Mar 31 18:29:18 GMT 2025
|
PRIMARY |